Poly Medicure Ltd
NSE:POLYMED

Watchlist Manager
Poly Medicure Ltd Logo
Poly Medicure Ltd
NSE:POLYMED
Watchlist
Price: 2 826.2 INR 1.83% Market Closed
Market Cap: 286.4B INR
Have any thoughts about
Poly Medicure Ltd?
Write Note

Profitability Summary

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

To be successful and remain in business, both growth and profitability are important and necessary. Net Income growth is often seen as a sign of a company's efficiency from an operational standpoint, but is influenced heavily by a company's goals and challenges and should therefore be assessed in conjunction with other metrics like revenue and operating income growth.

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Earnings Waterfall
Poly Medicure Ltd

Revenue
15.2B INR
Cost of Revenue
-5.1B INR
Gross Profit
10.1B INR
Operating Expenses
-6.8B INR
Operating Income
3.3B INR
Other Expenses
-382.6m INR
Net Income
2.9B INR

Margins Comparison
Poly Medicure Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
IN
Poly Medicure Ltd
NSE:POLYMED
286.3B INR
67%
22%
19%
JP
Hoya Corp
TSE:7741
6.8T JPY
86%
28%
24%
CH
Alcon AG
SIX:ALC
37.8B CHF
55%
13%
12%
DK
Coloplast A/S
CSE:COLO B
175.9B DKK
68%
27%
19%
US
Align Technology Inc
NASDAQ:ALGN
16.3B USD
70%
17%
11%
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
52.2B CNY
72%
45%
42%
KR
HLB Inc
KOSDAQ:028300
10.1T KRW
15%
-245%
-358%
US
Lantheus Holdings Inc
NASDAQ:LNTH
6.5B USD
65%
32%
29%
CA
Bausch + Lomb Corp
NYSE:BLCO
6.4B USD
61%
4%
-8%
UK
ConvaTec Group PLC
LSE:CTEC
4.5B GBP
56%
13%
7%
US
Merit Medical Systems Inc
NASDAQ:MMSI
5.6B USD
47%
12%
9%
Country IN
Market Cap 286.3B INR
Gross Margin
67%
Operating Margin
22%
Net Margin
19%
Country JP
Market Cap 6.8T JPY
Gross Margin
86%
Operating Margin
28%
Net Margin
24%
Country CH
Market Cap 37.8B CHF
Gross Margin
55%
Operating Margin
13%
Net Margin
12%
Country DK
Market Cap 175.9B DKK
Gross Margin
68%
Operating Margin
27%
Net Margin
19%
Country US
Market Cap 16.3B USD
Gross Margin
70%
Operating Margin
17%
Net Margin
11%
Country CN
Market Cap 52.2B CNY
Gross Margin
72%
Operating Margin
45%
Net Margin
42%
Country KR
Market Cap 10.1T KRW
Gross Margin
15%
Operating Margin
-245%
Net Margin
-358%
Country US
Market Cap 6.5B USD
Gross Margin
65%
Operating Margin
32%
Net Margin
29%
Country CA
Market Cap 6.4B USD
Gross Margin
61%
Operating Margin
4%
Net Margin
-8%
Country UK
Market Cap 4.5B GBP
Gross Margin
56%
Operating Margin
13%
Net Margin
7%
Country US
Market Cap 5.6B USD
Gross Margin
47%
Operating Margin
12%
Net Margin
9%
No Stocks Found

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Return on Capital Comparison
Poly Medicure Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
IN
Poly Medicure Ltd
NSE:POLYMED
286.3B INR
15%
12%
17%
17%
JP
Hoya Corp
TSE:7741
6.8T JPY
21%
17%
23%
31%
CH
Alcon AG
SIX:ALC
37.8B CHF
6%
4%
5%
5%
DK
Coloplast A/S
CSE:COLO B
175.9B DKK
29%
11%
21%
13%
US
Align Technology Inc
NASDAQ:ALGN
16.3B USD
11%
7%
16%
9%
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
52.2B CNY
25%
23%
27%
36%
KR
HLB Inc
KOSDAQ:028300
10.1T KRW
-33%
-22%
-17%
-17%
US
Lantheus Holdings Inc
NASDAQ:LNTH
6.5B USD
46%
24%
36%
35%
CA
Bausch + Lomb Corp
NYSE:BLCO
6.4B USD
-5%
-3%
2%
2%
UK
ConvaTec Group PLC
LSE:CTEC
4.5B GBP
9%
4%
9%
7%
US
Merit Medical Systems Inc
NASDAQ:MMSI
5.6B USD
9%
6%
8%
7%
Country IN
Market Cap 286.3B INR
ROE
15%
ROA
12%
ROCE
17%
ROIC
17%
Country JP
Market Cap 6.8T JPY
ROE
21%
ROA
17%
ROCE
23%
ROIC
31%
Country CH
Market Cap 37.8B CHF
ROE
6%
ROA
4%
ROCE
5%
ROIC
5%
Country DK
Market Cap 175.9B DKK
ROE
29%
ROA
11%
ROCE
21%
ROIC
13%
Country US
Market Cap 16.3B USD
ROE
11%
ROA
7%
ROCE
16%
ROIC
9%
Country CN
Market Cap 52.2B CNY
ROE
25%
ROA
23%
ROCE
27%
ROIC
36%
Country KR
Market Cap 10.1T KRW
ROE
-33%
ROA
-22%
ROCE
-17%
ROIC
-17%
Country US
Market Cap 6.5B USD
ROE
46%
ROA
24%
ROCE
36%
ROIC
35%
Country CA
Market Cap 6.4B USD
ROE
-5%
ROA
-3%
ROCE
2%
ROIC
2%
Country UK
Market Cap 4.5B GBP
ROE
9%
ROA
4%
ROCE
9%
ROIC
7%
Country US
Market Cap 5.6B USD
ROE
9%
ROA
6%
ROCE
8%
ROIC
7%
No Stocks Found

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.